(jofem.org) The best-case signal: modest weight loss in a shorter trial A frequently cited 12-week randomized trial result (as summarized in reviews) reported: ~2.6 kg average loss with AOD-9604 1 mg/day vs ~0.8 kg with placebo (PMC) This is the kind of result that can be statistically meaningful, clinically modest, and very sensitive to study design (diet, activity, baseline metabolic status, adherence)
30 mL multi-dose plastic vial
4 Journal of Human Kinetics
Understanding this timeline helps set realistic expectations and prevents unnecessary worry during early treatment
The vitamin is delivered straight into your muscle, allowing it to be absorbed directly into your bloodstream
Expanding application scope to explore interventions in aging-related diseases (neurodegenerative diseases, cardiovascular diseases, metabolic diseases), providing new strategies for their prevention and treatment